Clariane SE (CLARI) - Net Assets

Latest as of December 2025: €3.92 Billion EUR ≈ $4.58 Billion USD

Based on the latest financial reports, Clariane SE (CLARI) has net assets worth €3.92 Billion EUR (≈ $4.58 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.81 Billion ≈ $16.14 Billion USD) and total liabilities (€9.89 Billion ≈ $11.56 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Clariane SE (CLARI) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets €3.92 Billion
% of Total Assets 28.38%
Annual Growth Rate 16.45%
5-Year Change 4.09%
10-Year Change 92.37%
Growth Volatility 44.72

Clariane SE - Net Assets Trend (2004–2025)

This chart illustrates how Clariane SE's net assets have evolved over time, based on quarterly financial data. Also explore Clariane SE (CLARI) total assets for the complete picture of this company's asset base.

Annual Net Assets for Clariane SE (2004–2025)

The table below shows the annual net assets of Clariane SE from 2004 to 2025. For live valuation and market cap data, see market value of Clariane SE.

Year Net Assets Change
2025-12-31 €3.92 Billion
≈ $4.58 Billion
-2.55%
2024-12-31 €4.02 Billion
≈ $4.70 Billion
+2.12%
2023-12-31 €3.94 Billion
≈ $4.60 Billion
+1.80%
2022-12-31 €3.87 Billion
≈ $4.52 Billion
+2.75%
2021-12-31 €3.76 Billion
≈ $4.40 Billion
+13.30%
2020-12-31 €3.32 Billion
≈ $3.88 Billion
+29.30%
2019-12-31 €2.57 Billion
≈ $3.00 Billion
+0.06%
2018-12-31 €2.57 Billion
≈ $3.00 Billion
+3.77%
2017-12-31 €2.47 Billion
≈ $2.89 Billion
+21.49%
2016-12-31 €2.04 Billion
≈ $2.38 Billion
+5.33%
2015-12-31 €1.93 Billion
≈ $2.26 Billion
+1.65%
2014-12-31 €1.90 Billion
≈ $2.22 Billion
+147.59%
2013-12-31 €768.43 Million
≈ $898.37 Million
+4.87%
2012-12-31 €732.75 Million
≈ $856.66 Million
+1.38%
2011-12-31 €722.78 Million
≈ $845.00 Million
+0.62%
2010-12-31 €718.32 Million
≈ $839.79 Million
+2.51%
2009-12-31 €700.70 Million
≈ $819.19 Million
+8.63%
2008-12-31 €645.02 Million
≈ $754.09 Million
-0.40%
2007-12-31 €647.61 Million
≈ $757.13 Million
+2.79%
2006-12-31 €630.04 Million
≈ $736.59 Million
+50.69%
2005-12-31 €418.09 Million
≈ $488.79 Million
+161.20%
2004-12-31 €160.06 Million
≈ $187.13 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Clariane SE's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock €3.57 Million 0.10%
Other Components €3.61 Billion 99.90%
Total Equity €3.61 Billion 100.00%

Clariane SE Competitors by Market Cap

The table below lists competitors of Clariane SE ranked by their market capitalization.

Company Market Cap
Jiangsu Yinhe Electronics Co Ltd
SHE:002519
$1.34 Billion
Gelex Group JSC
VN:GEX
$1.34 Billion
Land and Houses Public Company Limited
BK:LH
$1.34 Billion
Inox Wind Energy Limited
NSE:IWEL
$1.34 Billion
Dorchester Minerals LP
NASDAQ:DMLP
$1.34 Billion
Guangdong Shenglu Telecommunication Tech Co Ltd
SHE:002446
$1.34 Billion
Shenzhen Sunrise New Energy Co Ltd
SHE:002256
$1.34 Billion
Develia S.A
WAR:DVL
$1.34 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Clariane SE's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,692,284,000 to 3,613,664,000, a change of -78,620,000 (-2.1%).
  • Net income of 1,600,000 contributed positively to equity growth.
  • Dividend payments of 69,956,000 reduced retained earnings.
  • Share repurchases of 3,565,000 reduced equity.
  • Other comprehensive income decreased equity by 708,405,000.
  • Other factors increased equity by 705,226,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €1.60 Million +0.04%
Dividends Paid €69.96 Million -1.94%
Share Repurchases €3.56 Million -0.1%
Other Comprehensive Income €-708.40 Million -19.6%
Other Changes €705.23 Million +19.52%
Total Change €- -2.13%

Book Value vs Market Value Analysis

This analysis compares Clariane SE's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.40x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.76x to 0.40x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 €5.33 €4.04 x
2005-12-31 €13.24 €4.04 x
2006-12-31 €20.90 €4.04 x
2007-12-31 €21.29 €4.04 x
2008-12-31 €19.42 €4.04 x
2009-12-31 €19.97 €4.04 x
2010-12-31 €19.92 €4.04 x
2011-12-31 €19.50 €4.04 x
2012-12-31 €19.07 €4.04 x
2013-12-31 €19.98 €4.04 x
2014-12-31 €22.15 €4.04 x
2015-12-31 €22.22 €4.04 x
2016-12-31 €22.30 €4.04 x
2017-12-31 €25.86 €4.04 x
2018-12-31 €26.54 €4.04 x
2019-12-31 €26.56 €4.04 x
2020-12-31 €29.84 €4.04 x
2021-12-31 €28.59 €4.04 x
2022-12-31 €29.38 €4.04 x
2023-12-31 €24.62 €4.04 x
2024-12-31 €15.96 €4.04 x
2025-12-31 €10.16 €4.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Clariane SE utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.04%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.03%
  • • Asset Turnover: 0.38x
  • • Equity Multiplier: 3.82x
  • Recent ROE (0.04%) is below the historical average (2.99%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 4.03% 4.01% 0.29x 3.43x €-9.53 Million
2005 7.44% 10.46% 0.24x 2.96x €-10.16 Million
2006 3.15% 3.84% 0.41x 1.99x €-42.94 Million
2007 3.62% 3.80% 0.36x 2.63x €-40.69 Million
2008 2.88% 2.31% 0.45x 2.76x €-44.68 Million
2009 2.17% 1.76% 0.47x 2.64x €-53.94 Million
2010 3.52% 2.67% 0.49x 2.70x €-45.47 Million
2011 3.08% 2.14% 0.49x 2.97x €-48.61 Million
2012 3.27% 2.10% 0.50x 3.13x €-47.95 Million
2013 3.83% 2.11% 0.59x 3.11x €-46.01 Million
2014 3.22% 2.76% 0.42x 2.76x €-129.15 Million
2015 3.05% 2.28% 0.45x 3.00x €-133.58 Million
2016 6.49% 4.40% 0.46x 3.21x €-71.01 Million
2017 6.63% 5.22% 0.44x 2.89x €-82.92 Million
2018 4.82% 3.69% 0.44x 2.98x €-132.49 Million
2019 4.48% 3.17% 0.33x 4.28x €-141.14 Million
2020 1.25% 1.04% 0.29x 4.18x €-276.30 Million
2021 2.61% 2.20% 0.29x 4.10x €-258.21 Million
2022 0.62% 0.50% 0.30x 4.12x €-331.86 Million
2023 -2.94% -2.11% 0.33x 4.24x €-463.62 Million
2024 -1.49% -1.04% 0.37x 3.86x €-424.35 Million
2025 0.04% 0.03% 0.38x 3.82x €-359.77 Million

Industry Comparison

This section compares Clariane SE's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $1,011,515,667
  • Average return on equity (ROE) among peers: -4.50%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Clariane SE (CLARI) €3.92 Billion 4.03% 2.52x $1.34 Billion
EMEIS SA (EMEIS) $1.72 Billion -23.93% 6.79x $2.24 Billion
Ramsay Generale De Sante (GDS) $1.28 Billion 3.87% 4.45x $1.18 Billion
LNA Sante SA (LNA) $35.72 Million 6.56% 2.09x $271.76 Million

About Clariane SE

PA:CLARI France Medical Care Facilities
Market Cap
$1.68 Billion
€1.44 Billion EUR
Market Cap Rank
#7844 Global
#128 in France
Share Price
€4.04
Change (1 day)
+0.40%
52-Week Range
€3.32 - €5.36
All Time High
€24.48
About

Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care … Read more